BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2010
View Archived Issues
3SBio and Panacor sign agreement to develop and commercialize Nephoxil in China
Read More
Ticagrelor better option than clopidogrel in patients with acute coronary syndromes
Read More
FYO-750 improves bladder capacity in neurogenic detrusor overactivity in rats
Read More
Tamoxifen plus chemotherapy beneficial in postmenopausal breast cancer patients
Read More
The CXCR1antagonist repertaxin targets breast cancer stem cells in vivo
Read More
New LXRbeta agonists discovered by Kowa
Read More
Concert Pharmaceuticals describes novel DPP-IV inhibitors
Read More
Trigemina begins phase IIa oxytocin trial in chronic daily headache
Read More
Bristol-Myers Squibb reports the discovery of novel MCH-R1 antagonists
Read More
Wyeth identifies novel 5-HT6 receptor ligands
Read More
CRUK to fund trial of Advaxis' HPV vaccine in head and neck cancer
Read More
Cancer Research Technology claims novel dual CYP26 inhibitors/RAMBAs
Read More
QR Pharma initiates Posiphen trial in cognitively impaired patients
Read More
Phase I trial commences for NPC-1C in pancreatic and colorectal cancer
Read More
Biovail and Alexza to commercialize and develop AZ-004 for multiple indications
Read More
ReNeuron receives approval for landmark trial of ReN-001 stem cell therapy in stroke
Read More
Novartis describes identification of compounds targeting PI3K
Read More
Phase III mipomersen study meets primary endpoint in heFH
Read More
Naurex reports topline phase I results on GLYX-13 for depression
Read More
Vertex reports full-year 2009 R&D highlights
Read More
Tekmira presents update on its activities for 2010
Read More
FDA approves AstraZeneca's Crestor for heart disease
Read More
4SC begins dosing in first-in-man phase I trial of 4SC-205 in cancer
Read More
Intercell reports phase I results of S. pneumoniae vaccine IC-47
Read More
Roche reports positive results from phase III clinical program of taspoglutide in diabetes
Read More
